Lorne Albrecht
University of British Columbia(CA)Probity Medical Research(CA)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Autoimmune Bullous Skin Diseases, Allergic Rhinitis and Sensitization, Asthma and respiratory diseases
Most-Cited Works
- → A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial(2019)168 cited
- → Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis(2023)127 cited
- → Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis(2022)107 cited
- → Economic burden of moderate to severe plaque psoriasis in Canada(2012)64 cited
- → Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial(2021)52 cited
- → Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section IV: Treatment Options for the Management of Atopic Dermatitis(2018)25 cited
- → Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document(2018)23 cited
- → Topical Psoriasis Therapy in the Age of Biologics: Evidence-Based Treatment Recommendations(2011)13 cited
- → Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: A 52-week, phase 2, open-label trial(2024)13 cited
- → Efficacy and safety of ingenol mebutate gel in field treatment of actinic keratosis on full face, balding scalp, or approximately 250 cm2 on the chest: A phase 3 randomized controlled trial(2019)11 cited